Drug Database
BF

BF57KO (BF57KO / Bioflorin)

✓ Approved

Rottapharm Madaus · Cell-based Therapies · Cell-based Therapies

What is BF57KO?

BF57KO is a cell-based therapies developed by Rottapharm Madaus. It is approved for therapeutic indications via oral (po).

Drug Profile

Brand NamesBF57KO, Bioflorin
CompanyRottapharm Madaus
Drug ClassCell-based Therapies
RouteOral (PO)
StatusApproved
Sources: ClinicalTrials.gov, Rottapharm Madaus

Therapeutic Indications

BF57KO is developed for 1 unique indication across 1 therapeutic area.

Therapeutic AreaConditionPhase
Gastrointestinal disordersDiarrhoea✓ Approved

Ask about BF57KO